Abatacept improves survival in patients with acute GvHD – European Pharmaceutical Review
European Pharmaceutical ReviewAbatacept improves survival in patients with acute GvHDEuropean Pharmaceutical ReviewResults from a phase 2 clinical trial, show that the drug Abatacept (Orencia) nearly eliminated life-threatening severe acute graft-versu…